Moxibustion for depression: A meta-analysis.
- 1Department of Psychiatry, Shandong Mental Health Center, Ji'nan, Shandong Province, China.
- 2Institute of Mental Health, Jining Medical University, Jining, China.
- 3Department of Sleep Medicine, Guangxi Zhuang Autonomous Region Brain Hospital, Liuzhou, Guangxi, China.
Abstract
Background
Moxibustion, a traditional Chinese medicine therapy, is widely used for various diseases and has recently been applied in treating depression. This study aims to systematically assess the efficacy and safety of moxibustion, either alone or in combination with other therapies, for depression.Methods
We conducted a comprehensive search across 7 databases from their inception to December 20, 2023, focusing on randomized controlled trials that compared moxibustion with sham treatments, no treatment, or conventional therapies. The primary outcomes were the overall effective rate and Hamilton Depression Rating Scale scores, with adverse reaction incidence as the secondary outcome. Data were analyzed with RevMan 5.4 and Stata 18, with bias risk assessed using the Cochrane Risk of Bias tool. Evidence quality was graded with GRADEpro.Results
This study included 15 randomized controlled trials with 1510 patients. Meta-analysis results showed that moxibustion, alone or combined with other therapies, was more effective than other treatments for managing depression (relative risk = 1.07, 95% confidence interval [CI]: [1.03-1.10], P = .0003). Moxibustion, either alone or in combination with other treatments, significantly reduced Hamilton Depression Rating Scale scores compared to other treatments used alone (mean difference = -2.10, 95% CI: [-3.00 to -1.20]), with its efficacy comparable to that of antidepressant medications (mean difference = -0.60, 95% CI [-1.31 to 0.12], P = .10). Additionally, in terms of safety, the incidence of adverse reactions associated with moxibustion alone or in combination with other therapies for depression is relatively low (relative risk = 0.57, 95% CI: [0.39-0.84], P = .005). However, the overall quality of the evidence was assessed as low to very low.Conclusion
Moxibustion has been shown to alleviate depressive symptoms, particularly when combined with other therapies, offering both enhanced efficacy and safety. However, further high-quality studies are necessary to confirm its effectiveness.
Related
- Moxibustion and the gut microbiota-inflammation axis: a systematic review and meta-analysis of clinical and preclinical studies.
- Comparative efficacy of digital health intervention delivery modalities on quality of life, anxiety, and depression in coronary heart disease: a systematic review and network meta-analysis
- Factor Structure and Symptom Profiles of the Montgomery–Åsberg Depression Rating Scale (MADRS): A Meta-Analytic Mean and Covariance Structure Analysis
- Dissecting the pro-neurogenic effects of monoaminergic medications used to treat depression: a systematic review and meta-analysis
- Adjunctive effects of acupuncture and moxibustion in women with premature ovarian insufficiency receiving hormone replacement therapy: protocol for a multicenter, assessor-blinded, 2 × 2 factorial randomized controlled trial
BibTeX
@article{li2026moxibustion,
title = {{Moxibustion for depression: A meta-analysis.}},
author = {Yingcun Li and Minling Li and Fengxia Sun and Yijin Xie and Xu Li and Aihua Yin and Zengxun Liu and Xin Li},
journal = {Medicine},
year = {2026},
month = oct,
doi = {10.1097/md.0000000000051032},
url = {https://europepmc.org/article/MED/42888532},
note = {CC BY-NC},
}
RIS
TY - JOUR
TI - Moxibustion for depression: A meta-analysis.
AU - Yingcun Li
AU - Minling Li
AU - Fengxia Sun
AU - Yijin Xie
AU - Xu Li
AU - Aihua Yin
AU - Zengxun Liu
AU - Xin Li
PY - 2026
DA - 2026/10/01
JO - Medicine
DO - 10.1097/md.0000000000051032
UR - https://europepmc.org/article/MED/42888532
AB - Background Moxibustion, a traditional Chinese medicine therapy, is widely used for various diseases and has recently been applied in treating depression. This study aims to systematically assess the efficacy and safety of moxibustion, either alone or in combination with other therapies, for depression.Methods We conducted a comprehensive search across 7 databases from their inception to December 20, 2023, focusing on randomized controlled trials that compared moxibustion with sham treatments, no treatment, or conventional therapies. The primary outcomes were the overall effective rate and Hamilton Depression Rating Scale scores, with adverse reaction incidence as the secondary outcome. Data were analyzed with RevMan 5.4 and Stata 18, with bias risk assessed using the Cochrane Risk of Bias tool. Evidence quality was graded with GRADEpro.Results This study included 15 randomized controlled trials with 1510 patients. Meta-analysis results showed that moxibustion, alone or combined with other therapies, was more effective than other treatments for managing depression (relative risk = 1.07, 95% confidence interval [CI]: [1.03-1.10], P = .0003). Moxibustion, either alone or in combination with other treatments, significantly reduced Hamilton Depression Rating Scale scores compared to other treatments used alone (mean difference = -2.10, 95% CI: [-3.00 to -1.20]), with its efficacy comparable to that of antidepressant medications (mean difference = -0.60, 95% CI [-1.31 to 0.12], P = .10). Additionally, in terms of safety, the incidence of adverse reactions associated with moxibustion alone or in combination with other therapies for depression is relatively low (relative risk = 0.57, 95% CI: [0.39-0.84], P = .005). However, the overall quality of the evidence was assessed as low to very low.Conclusion Moxibustion has been shown to alleviate depressive symptoms, particularly when combined with other therapies, offering both enhanced efficacy and safety. However, further high-quality studies are necessary to confirm its effectiveness.
SN - 0304-5412
SN - 1536-5964
ER -